Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring

Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of nuclear medicine and molecular imaging 2010-08, Vol.37 (9), p.1643-1653
Hauptverfasser: Murray, Iain, Kalemis, Antonis, Glennon, Joe, Hasan, Syed, Quraishi, Shuaib, Beyer, Thomas, Avril, Norbert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1653
container_issue 9
container_start_page 1643
container_title European journal of nuclear medicine and molecular imaging
container_volume 37
creator Murray, Iain
Kalemis, Antonis
Glennon, Joe
Hasan, Syed
Quraishi, Shuaib
Beyer, Thomas
Avril, Norbert
description Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT. Methods We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq) 18 F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics. Results In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV. Conclusion Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies.
doi_str_mv 10.1007/s00259-010-1466-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748927237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748927237</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</originalsourceid><addsrcrecordid>eNp1kUFrGzEQhUVJaRwnP6CXIHLpSfVIK620uQXjpoVAe3DPQtZqbYXd1UbSpvjfd41dBwI9zQx88-YxD6HPFL5SALlIAExUBCgQysuSiA9oRktaEQmqujj3Ei7RVUrPAFQxVX1Clww4U6osZ2i39p0joSFN67e7jH-t1ovlGo_J91vchj_E2Oxffd7jIYYcbGjTPR5Cdn32psW-G1pvTfahT7gJEVvTWxdx3rlohj3uQu9ziJPYNfrYmDa5m1Odo9_fVuvld_L08_HH8uGJWF6UmSghpeIFKMFrVQvVUFkK7kolrKCW1oY50TAGjAKlNRhbMbHZbKwxlvNCNsUcfTnqTn5fRpey7nyyrm1N78KYtOSqYpIVciLv3pHPYYz9ZE4ryahkqqgmiB4hG0NK0TV6iL4zca8p6EMI-hiChsM8haDFtHN7Eh43navPG_--PgHsCKTh8BoX3y7_X_UvIL2R9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>872172839</pqid></control><display><type>article</type><title>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Murray, Iain ; Kalemis, Antonis ; Glennon, Joe ; Hasan, Syed ; Quraishi, Shuaib ; Beyer, Thomas ; Avril, Norbert</creator><creatorcontrib>Murray, Iain ; Kalemis, Antonis ; Glennon, Joe ; Hasan, Syed ; Quraishi, Shuaib ; Beyer, Thomas ; Avril, Norbert</creatorcontrib><description>Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT. Methods We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq) 18 F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics. Results In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV. Conclusion Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-010-1466-5</identifier><identifier>PMID: 20428866</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adult ; Cancer ; Cardiology ; Humans ; Imaging ; Medical imaging ; Medicine ; Medicine &amp; Public Health ; Neoplasms - diagnosis ; Neoplasms - diagnostic imaging ; Neoplasms - therapy ; Nuclear Medicine ; Oncology ; Original Article ; Orthopedics ; Phantoms, Imaging ; Positron-Emission Tomography - methods ; Radiology ; Reproducibility of Results ; Therapy ; Time Factors ; Tomography, X-Ray Computed - methods ; Treatment Outcome</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2010-08, Vol.37 (9), p.1643-1653</ispartof><rights>Springer-Verlag 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</citedby><cites>FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-010-1466-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-010-1466-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20428866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murray, Iain</creatorcontrib><creatorcontrib>Kalemis, Antonis</creatorcontrib><creatorcontrib>Glennon, Joe</creatorcontrib><creatorcontrib>Hasan, Syed</creatorcontrib><creatorcontrib>Quraishi, Shuaib</creatorcontrib><creatorcontrib>Beyer, Thomas</creatorcontrib><creatorcontrib>Avril, Norbert</creatorcontrib><title>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT. Methods We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq) 18 F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics. Results In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV. Conclusion Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies.</description><subject>Adult</subject><subject>Cancer</subject><subject>Cardiology</subject><subject>Humans</subject><subject>Imaging</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - diagnostic imaging</subject><subject>Neoplasms - therapy</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Phantoms, Imaging</subject><subject>Positron-Emission Tomography - methods</subject><subject>Radiology</subject><subject>Reproducibility of Results</subject><subject>Therapy</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed - methods</subject><subject>Treatment Outcome</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUFrGzEQhUVJaRwnP6CXIHLpSfVIK620uQXjpoVAe3DPQtZqbYXd1UbSpvjfd41dBwI9zQx88-YxD6HPFL5SALlIAExUBCgQysuSiA9oRktaEQmqujj3Ei7RVUrPAFQxVX1Clww4U6osZ2i39p0joSFN67e7jH-t1ovlGo_J91vchj_E2Oxffd7jIYYcbGjTPR5Cdn32psW-G1pvTfahT7gJEVvTWxdx3rlohj3uQu9ziJPYNfrYmDa5m1Odo9_fVuvld_L08_HH8uGJWF6UmSghpeIFKMFrVQvVUFkK7kolrKCW1oY50TAGjAKlNRhbMbHZbKwxlvNCNsUcfTnqTn5fRpey7nyyrm1N78KYtOSqYpIVciLv3pHPYYz9ZE4ryahkqqgmiB4hG0NK0TV6iL4zca8p6EMI-hiChsM8haDFtHN7Eh43navPG_--PgHsCKTh8BoX3y7_X_UvIL2R9A</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Murray, Iain</creator><creator>Kalemis, Antonis</creator><creator>Glennon, Joe</creator><creator>Hasan, Syed</creator><creator>Quraishi, Shuaib</creator><creator>Beyer, Thomas</creator><creator>Avril, Norbert</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100801</creationdate><title>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</title><author>Murray, Iain ; Kalemis, Antonis ; Glennon, Joe ; Hasan, Syed ; Quraishi, Shuaib ; Beyer, Thomas ; Avril, Norbert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Cancer</topic><topic>Cardiology</topic><topic>Humans</topic><topic>Imaging</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - diagnostic imaging</topic><topic>Neoplasms - therapy</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Phantoms, Imaging</topic><topic>Positron-Emission Tomography - methods</topic><topic>Radiology</topic><topic>Reproducibility of Results</topic><topic>Therapy</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murray, Iain</creatorcontrib><creatorcontrib>Kalemis, Antonis</creatorcontrib><creatorcontrib>Glennon, Joe</creatorcontrib><creatorcontrib>Hasan, Syed</creatorcontrib><creatorcontrib>Quraishi, Shuaib</creatorcontrib><creatorcontrib>Beyer, Thomas</creatorcontrib><creatorcontrib>Avril, Norbert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murray, Iain</au><au>Kalemis, Antonis</au><au>Glennon, Joe</au><au>Hasan, Syed</au><au>Quraishi, Shuaib</au><au>Beyer, Thomas</au><au>Avril, Norbert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2010-08-01</date><risdate>2010</risdate><volume>37</volume><issue>9</issue><spage>1643</spage><epage>1653</epage><pages>1643-1653</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT. Methods We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq) 18 F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics. Results In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV. Conclusion Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>20428866</pmid><doi>10.1007/s00259-010-1466-5</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1619-7070
ispartof European journal of nuclear medicine and molecular imaging, 2010-08, Vol.37 (9), p.1643-1653
issn 1619-7070
1619-7089
language eng
recordid cdi_proquest_miscellaneous_748927237
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Cancer
Cardiology
Humans
Imaging
Medical imaging
Medicine
Medicine & Public Health
Neoplasms - diagnosis
Neoplasms - diagnostic imaging
Neoplasms - therapy
Nuclear Medicine
Oncology
Original Article
Orthopedics
Phantoms, Imaging
Positron-Emission Tomography - methods
Radiology
Reproducibility of Results
Therapy
Time Factors
Tomography, X-Ray Computed - methods
Treatment Outcome
title Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A37%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time-of-flight%20PET/CT%20using%20low-activity%20protocols:%20potential%20implications%20for%20cancer%20therapy%20monitoring&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Murray,%20Iain&rft.date=2010-08-01&rft.volume=37&rft.issue=9&rft.spage=1643&rft.epage=1653&rft.pages=1643-1653&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-010-1466-5&rft_dat=%3Cproquest_cross%3E748927237%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=872172839&rft_id=info:pmid/20428866&rfr_iscdi=true